Masimo Corp MASI
News
-
Masimo Provides Leadership and Business Updates
-
Politan Comments on Results of Masimo’s 2024 Annual Meeting
-
Leading Proxy Advisory Firm Glass Lewis Reiterates Recommendation That Masimo Shareholders Vote FOR Both of Politan’s Independent Director Nominees
-
Politan Highlights Need for Further Change in Masimo’s Boardroom Ahead of Thursday’s Annual Meeting
-
Masimo Shares Final Thoughts Ahead of September 19 Annual Meeting Where Everything is at Stake
-
Politan Comments on Masimo’s Latest Attempt to Block a Fair Shareholder Vote
-
Masimo Partners with Qualcomm to Develop Next-Generation Smartwatch Reference Platform for Original Equipment Manufacturers
-
Masimo Partners with Google to Develop a Reference Platform That Helps Device Manufacturers Bring High-performing Wear OS Smartwatches to Market
Trading Information
- Previous Close Price
- $133.10
- Day Range
- $131.01–135.27
- 52-Week Range
- $75.22–153.93
- Bid/Ask
- $41.00 / $146.00
- Market Cap
- $7.12 Bil
- Volume/Avg
- 607,471 / 712,789
Key Statistics
- Price/Earnings (Normalized)
- 38.06
- Price/Sales
- 3.57
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,796
- Website
- https://www.masimo.com
Comparables
Valuation
|
Metric
|
MASI
|
300451
|
603990
|
|---|---|---|---|
Price/Earnings (Normalized) | 38.06 | 69.99 | — |
Price/Book Value | 5.18 | 1.36 | 2.90 |
Price/Sales | 3.57 | 4.77 | 4.11 |
Price/Cash Flow | 39.14 | 20.68 | — |
Price/Earnings
MASI
300451
603990
Financial Strength
|
Metric
|
MASI
|
300451
|
603990
|
|---|---|---|---|
Quick Ratio | 0.98 | 2.68 | 0.40 |
Current Ratio | 2.09 | 3.00 | 0.55 |
Interest Coverage | 2.57 | 30.40 | −2.81 |
Quick Ratio
MASI
300451
603990
Profitability
|
Metric
|
MASI
|
300451
|
603990
|
|---|---|---|---|
Return on Assets (Normalized) | 4.59% | 0.71% | −10.67% |
Return on Equity (Normalized) | 10.23% | 0.88% | −33.36% |
Return on Invested Capital (Normalized) | 7.91% | 0.47% | −13.85% |
Return on Assets
MASI
300451
603990
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Spvfvmhkq | Drcfjn | $195.6 Bil | |||
| Stryker Corp
SYK
| Kffpdwlxt | Yxwgg | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Dxvjnpqc | Wyywcl | $122.7 Bil | |||
| Medtronic PLC
MDT
| Kqzvftbk | Xcjvrrl | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Fnwhnwty | Btwdfrh | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Gsnp | Kdcs | $30.7 Bil | |||
| DexCom Inc
DXCM
| Jvnrztglrj | Sbpxz | $27.0 Bil | |||
| Steris PLC
STE
| Lgrhyfbn | Whypwz | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Sqdlnztqy | Pvfs | $22.0 Bil | |||
| Insulet Corp
PODD
| Jvqqqjslb | Bmcxbw | $16.3 Bil |
United States